Article
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer
Affiliations
Organisations
- (1) Institute of Cancer Research, grid.18886.3f
- (2) Karolinska Institute, grid.4714.6
- (3) University of Cambridge, grid.5335.0
- (4) University of Oxford, grid.4991.5
- (5) University of Bristol, grid.5337.2
- (6) Cancer Council Victoria, grid.3263.4
- (7) University of Melbourne, grid.1008.9
- (8) University of Southern California, grid.42505.36
- (9) Harvard University, grid.38142.3c
- (10) American Cancer Society, grid.422418.9
- (11) National Institute of Arthritis and Musculoskeletal and Skin Diseases, grid.420086.8
- (12) Washington University in St. Louis, grid.4367.6
- (13) University of Turku, grid.1374.1
- (14) Herlev Hospital, grid.411900.d, Capital Region
- (15) German Cancer Research Center, grid.7497.d
- (16) Imperial College London, grid.7445.2
- (17) Cancer Prevention Institute of California, grid.280669.3
- (18) Stanford University, grid.168010.e
- (19) New York University Langone Medical Center, grid.240324.3
- (20) Fred Hutchinson Cancer Research Center, grid.270240.3
- (21) National Human Genome Research Institute, grid.280128.1
- (22) International Epidemiology Institute, grid.419344.f
- (23) Mayo Clinic, grid.66875.3a
- (24) University Hospital Ulm, grid.410712.1
- (25) Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
- (26) Pomeranian Medical University, grid.107950.a
- (27) University of Utah, grid.223827.e
- (28) Moffitt Cancer Center, grid.468198.a
- (29) Medical University of Sofia, grid.410563.5
- (30) Queensland University of Technology, grid.1024.7
- (31) University of Porto, grid.5808.5
- (32) Wake Forest University, grid.241167.7
- (33) University of Warwick, grid.7372.1
Countries
Continents
Description
The HOXB13 gene has been implicated in prostate cancer (PrCa) susceptibility. We performed a high resolution fine-mapping analysis to comprehensively evaluate the association between common genetic variation across the HOXB genetic locus at 17q21 and PrCa risk. This involved genotyping 700 SNPs using a custom Illumina iSelect array (iCOGS) followed by imputation of 3195 SNPs in 20,440 PrCa cases and 21,469 controls in The PRACTICAL consortium. We identified a cluster of highly correlated common variants situated within or closely upstream of HOXB13 that were significantly associated with PrCa risk, described by rs117576373 (OR 1.30, P = 2.62×10(-14)). Additional genotyping, conditional regression and haplotype analyses indicated that the newly identified common variants tag a rare, partially correlated coding variant in the HOXB13 gene (G84E, rs138213197), which has been identified recently as a moderate penetrance PrCa susceptibility allele. The potential for GWAS associations detected through common SNPs to be driven by rare causal variants with higher relative risks has long been proposed; however, to our knowledge this is the first experimental evidence for this phenomenon of synthetic association contributing to cancer susceptibility.